Hongwei Chen
- Molecular Biology top 5%
- Cancer Research top 2%
- Biomedical Engineering top 5%
- Biomaterials top 5%
- Immunology top 10%
- Co-authors
- Duxin SunKanokwan SansanaphongprichaXin LuanHebao YuanHayley J. PaholakYe GanChunyan GuLanlan Shao
- Topics
- Nanoparticle-Based Drug Delivery (8 papers)Nanoplatforms for cancer theranostics (8 papers)Extracellular vesicles in disease (4 papers)
- Journals
- PLoS ONEBiomaterialsCancer Research
- Partner nations
- United StatesChinaGeorgia
In The Last Decade
Hongwei Chen
25 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Molecular Biology 1.6k
- Cancer Research 752
- Biomedical Engineering 504
- Biomaterials 328
- Immunology 275
Countries citing papers authored by Hongwei Chen
This map shows the geographic impact of Hongwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei Chen more than expected).
Fields of papers citing papers by Hongwei Chen
This network shows the impact of papers produced by Hongwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei Chen. The network helps show where Hongwei Chen may publish in the future.
Co-authorship network of co-authors of Hongwei Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Hongwei Chen. A scholar is included among the top collaborators of Hongwei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongwei Chen. Hongwei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 18 | |
| 5 | 103 | |
| 6 | 57 | |
| 7 | 16 | |
| 8 | Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasisbreakdown → | 336 |
| 9 | 124 | |
| 10 | Engineering exosomes as refined biological nanoplatforms for drug deliverybreakdown → | 951 |
| 11 | 44 | |
| 12 | 23 | |
| 13 | 29 | |
| 14 | 14 | |
| 15 | 14 | |
| 16 | 62 | |
| 17 | 105 | |
| 18 | 31 | |
| 19 | 61 | |
| 20 | 20 |
About Hongwei Chen
Hongwei Chen is a scholar working on Biomaterials, Biological Psychiatry and Cancer Research, having authored 26 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (8 papers) and Extracellular vesicles in disease (4 papers). The work is most often cited by research in Cancer Research (752 citations), Biomaterials (328 citations) and Molecular Biology (1.6k citations). Hongwei Chen has collaborated with scholars based in United States, China and Georgia. Frequent co-authors include Duxin Sun, Kanokwan Sansanaphongpricha, Xin Luan, Hebao Yuan, Hayley J. Paholak, Ye Gan, Chunyan Gu, Lanlan Shao, Hongyan Zhu and Joseph Burnett. Their work appears in journals such as PLoS ONE, Biomaterials and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.